Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy

International Journal of Cardiology

Volumn 108, Issue 2, 2006, Pages 237-243

  Nanas, John N ^a,c   Tsagalou, Eleftheria P ^a   Nanas, Serafim N ^b   Terrovitis, John V ^a   Tsolakis, Elias J ^a   Toumanidis, Savas ^a   Papazoglou, Panagiotis D ^a   Alexopoulos, George P ^a   Kanakakis, John ^a   Anastasiou Nana, Maria I ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Amiodarone; End stage heart failure; Inotropes; Reverse remodeling

Indexed keywords

AMIODARONE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; FUROSEMIDE; METOPROLOL; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT ATRIUM PRESSURE; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; LONG TERM CARE; LUNG CAPILLARY PRESSURE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; AMIODARONE; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR AGENTS; DOBUTAMINE; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 33644666431     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.05.010     Document Type: Article

References (44)

1. A. Mosterd, B. Cost, and A.W. Hoes The prognosis of heart failure in the general population: the Rotterdam Study Eur Heart J 22 2001 1318 1327
2. M.A. Konstam, M.W. Kronenberg, and M.F. Rousseau Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. For the SOLVD (Studies of Left Ventricular Dysfunction) Investigators Circulation 88 1993 2277 2283
3. B.A. Groenning, J.C. Nilsson, L. Sondergaard, T. Fritz-Hansen, H.B. Larsson, and P.R. Hildebrandt Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure J Am Coll Cardiol 36 2000 2072 2080
4. H.R. Levin, M.C. Oz, J.M. Chen, M. Packer, E.A. Rose, and D. Burkhoff Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading Circulation 91 1995 2717 2720
5. A. Zafeiridis, V. Jeevanandam, S.R. Houser, and K.B. Margulies Regression of cellular hypertrophy after left ventricular assist device support Circulation 98 1998 656 662
6. P.M. Heerdt, J.W. Holmes, and B. Cai Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure Circulation 102 2000 2713 2719
7. K. Dipla, J.A. Mattiello, V. Jeevanandam, S.R. Houser, and K.B. Margulies Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure Circulation 97 1998 2316 2322
8. J.D. Madigan, A. Barbone, and A.F. Choudhri Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device J Thorac Cardiovasc Surg 121 2001 902 908
9. D.M. Mancini, A. Beniaminovitz, and H. Levin Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure Circulation 98 1998 2383 2389
10. J. Muller, G. Wallukat, and Y.-G. Weng Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy Circulation 96 1997 542 549
11. E.F. Lewis, P.A. Johnson, W. Johnson, C. Collins, L. Griffin, and L.W. Stevenson Preferences for quality of life or survival expressed by patients with heart failure J Heart Lung Transplant 20 2001 1016 1024
12. L.W. Stevenson Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II. Chronic inotropic therapy Circulation 108 2003 492 497
13. G.M. Felker, and C.M. O'Connor Inotropic therapy for heart failure: an evidence-based approach Am Heart J 142 2001 393 401
14. J.N. Nanas, D.A. Kontoyannis, and G.P. Alexopoulos Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure Chest 119 2001 1173 1178
15. J.N. Nanas, E.P. Tsagalou, and J. Kanakakis Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study Chest 125 2004 1198 1204
16. G.W. Dec Jr., I.F. Palacios, and J.T. Fallon Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome N Engl J Med 312 1985 885 890
17. K.B. James, P.M. McCarthy, and J.D. Thomas Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure Circulation 92 suppl II 1995 II-191 II-195
18. D.J. Goldstein, N. Moazami, and J.A. Seldomridge Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels Ann Thorac Surg 63 1997 971 974
19. P.M. McCarthy, S. Nakatani, and R. Vargo Structural and left ventricular histologic changes after implantable LVAD insertion Ann Thorac Surg 59 1995 609 613
20. S.E. Belland, R. Grunstein, V. Jeevanandam, and H.J. Eisen The effect of sustained mechanical support with left ventricular assist devices on myocardial apoptosis in patients with severe dilated cardiomyopathy [abstract] J Heart Lung Transplant 17 1998 83 84
21. O.H. Frazier, C.R. Benedict, and B. Radovancevic Improved left ventricular function after chronic left ventricular unloading Ann Thorac Surg 62 1996 675 681
22. M. Yacoub, P. Tansley, and E. Birks Interim results of left ventricular assist device combination therapy for inducing clinical and haemodynamic recovery of end-stage dilated cardiomyopathy [abstract] Circulation 106 2002 II606
23. W.L. Holman, R.C. Bourge, and J.K. Kirklin Case report: circulatory support for seventy days with resolution of acute heart failure J Thorac Cardiovasc Surg 102 1991 932 934
24. M.A. Pfeffer, and E. Braunwald Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1990 1161 1172
25. G.S. Francis, S.R. Goldsmith, and M.T. Olivari The neurohormonal axis in congestive heart failure Ann Intern Med 101 1984 370 377
26. M. Packer The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure J Am Coll Cardiol 20 1992 248 254
27. M. Packer Neurohormonal interactions and adaptations in congestive heart failure Circulation 77 1988 721 730
28. J. Sadoshima, Y. Xu, H.S. Slayter, and S. Izumo Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro Cell 75 1993 977 984
29. L.H. Baur, J.J. Schipperheyn, and J. Baan Influence of angiotensin converting enzyme inhibition on pump function and cardiac contractility in patients with chronic congestive heart failure Br Heart J 65 1991 137 142
30. M.F. Rousseau, O. Gurne, D. Duprez Belgian RALES Investigators Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy J Am Coll Cardiol 40 2002 1596 1601
31. K.T. Weber, and C.G. Brilla Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system Circulation 83 1991 1849 1865
32. W.S. Colucci, M. Packer, and M.R. Bristow Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure Circulation 94 1996 2800 2806
33. C.M. O'Connor, W.A. Gattis, and B.F. Uretsky Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST) Am Heart J 138 1999 78 86
34. H.C. Doval, D.R. Nul, H.O. Grancelli, S.V. Perrone, G.R. Bortman, R. Curiel Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Randomised trial of low-dose amiodarone in severe congestive heart failure Lancet 344 1994 493 498
35. S.M. Heilbrunn, P. Shah, M.R. Bristow, H.A. Valantine, R. Ginsburg, and M.B. Fowler Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy Circulation 79 1989 483 490
36. M.R. Bristow, R. Ginsburg, and V. Umans Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure Circ Res 59 1986 297 309
37. E.J. Eichhorn, C.M. Heesch, and J.H. Barnett Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study J Am Coll Cardiol 24 1994 1310 1320
38. E.M. Gilbert, S.L. Olsen, D.G. Renlund, and M.R. Bristow Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy Am J Cardiol 71 1993 23C 29C
39. E.J. Eichhorn The paradox of beta-adrenergic blockade for the management of congestive heart failure Am J Med 92 1992 527 538
40. M. Metra, S. Nodari, and A. D'Aloia Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure J Am Coll Cardiol 40 2002 1248 1258
41. A. Das, and D. Harris Control of mitochondrial ATP synthase in heart cells: inactive to active transitions caused by beating or positive inotropic agents Cardiovasc Res 24 1990 411 417
42. M.G. Glass, I. Reis, and C.R. Cory Reversal of the negative treppe with β-blockers: role of sarcoplasmic reticulum function and myocardial energetics [abstract] Circulation 88 1993 I-526
43. F. Brouri, L. Findji, and O. Mediani Toxic cardiac effects of catecholamines: role of beta-adrenoceptor downregulation Eur J Pharmacol 456 2002 69 75
44. S.H. Lee, N. Doliba, M. Osbakken, M. Oz, and D. Mancini Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure J Thorac Cardiovasc Surg 116 1998 344 349